[go: up one dir, main page]

IL125195A - Pharmaceutical compositions comprising angiotensin converting enzyme inhibitor for treatment of dyspeptic symptoms - Google Patents

Pharmaceutical compositions comprising angiotensin converting enzyme inhibitor for treatment of dyspeptic symptoms

Info

Publication number
IL125195A
IL125195A IL12519596A IL12519596A IL125195A IL 125195 A IL125195 A IL 125195A IL 12519596 A IL12519596 A IL 12519596A IL 12519596 A IL12519596 A IL 12519596A IL 125195 A IL125195 A IL 125195A
Authority
IL
Israel
Prior art keywords
ace
treatment
inhibitor
pharmaceutical preparation
hydrochloride
Prior art date
Application number
IL12519596A
Other languages
English (en)
Other versions
IL125195A0 (en
Original Assignee
Pharmacore Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacore Ab filed Critical Pharmacore Ab
Publication of IL125195A0 publication Critical patent/IL125195A0/xx
Publication of IL125195A publication Critical patent/IL125195A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04—Homopolymers or copolymers of esters
    • C09J133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09J133/062—Copolymers with monomers not covered by C09J133/06
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04—Homopolymers or copolymers of esters
    • C09J133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09J133/08—Homopolymers or copolymers of acrylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00795—Plasters special helping devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00846—Plasters with transparent or translucent part
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/28—Non-macromolecular organic substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Materials For Medical Uses (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12519596A 1996-01-15 1996-12-20 Pharmaceutical compositions comprising angiotensin converting enzyme inhibitor for treatment of dyspeptic symptoms IL125195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600120A SE9600120D0 (sv) 1996-01-15 1996-01-15 Novel medical use
PCT/SE1996/001733 WO1997026014A1 (en) 1996-01-15 1996-12-20 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms

Publications (2)

Publication Number Publication Date
IL125195A0 IL125195A0 (en) 1999-03-12
IL125195A true IL125195A (en) 2001-11-25

Family

ID=20401013

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12519596A IL125195A (en) 1996-01-15 1996-12-20 Pharmaceutical compositions comprising angiotensin converting enzyme inhibitor for treatment of dyspeptic symptoms

Country Status (32)

Country Link
US (1) US5977159A (et)
EP (1) EP0876158B1 (et)
JP (1) JP2001501908A (et)
KR (1) KR19990076973A (et)
CN (1) CN1090031C (et)
AT (1) ATE218885T1 (et)
AU (1) AU710846B2 (et)
BR (1) BR9612483A (et)
CA (1) CA2240199A1 (et)
CZ (1) CZ222398A3 (et)
DE (1) DE69621834T2 (et)
DK (1) DK0876158T3 (et)
EE (1) EE03517B1 (et)
ES (1) ES2175182T3 (et)
HU (1) HUP9901353A3 (et)
ID (1) ID16186A (et)
IL (1) IL125195A (et)
IS (1) IS4778A (et)
MX (1) MX9805506A (et)
MY (1) MY129782A (et)
NO (1) NO983234L (et)
NZ (1) NZ325973A (et)
PL (1) PL327818A1 (et)
PT (1) PT876158E (et)
RU (1) RU2203092C2 (et)
SE (1) SE9600120D0 (et)
SI (1) SI0876158T1 (et)
SK (1) SK282781B6 (et)
TR (1) TR199801298T2 (et)
UA (1) UA49861C2 (et)
WO (1) WO1997026014A1 (et)
ZA (1) ZA9783B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012110A2 (en) * 1998-08-26 2000-03-09 Queen's University At Kingston Use of anti(w)pressor agents for vascular remodeling in genital dysfunction
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
AU2002308522A1 (en) * 2001-05-01 2002-11-11 University Of Southern California Methods for inhibiting tumor cell proliferation
WO2003075842A2 (en) * 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
US20050271657A1 (en) * 2004-06-08 2005-12-08 Australian Stem Cell Centre Ltd. Intermittent treatment regime for organ failure
EP1983827A4 (en) 2006-02-01 2013-07-10 Stuart L Weg USE OF ANTIFUNGAL COMPOSITIONS FOR TREATING UPPER GASTROINTESTINAL CONDITIONS
WO2009114461A2 (en) * 2008-03-10 2009-09-17 University Of Southern California Angiotensin (1-7) dosage forms and uses thereof
US8338565B2 (en) 2008-08-20 2012-12-25 Ensemble Therapeutics Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
BRPI1016026A2 (pt) * 2009-03-27 2016-05-10 Calpis Co Ltd composição, métodos para regular uma atividade nervosa autônoma, para promover a atividade nervosa parassimpática, para suprimir um aumento em uma atividade nervosa simpática em um animal não humano, para promover a motilidade gastrointestinal, para prevenir a amnésia, e, para reduzir a ansiedade, e, agente.
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA899367B (en) * 1988-12-22 1990-08-29 Yamanouchi Pharma Co Ltd 4,5,6,7-tetrahydrobenzimidazole derivatives
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension

Also Published As

Publication number Publication date
WO1997026014A1 (en) 1997-07-24
SE9600120D0 (sv) 1996-01-15
CA2240199A1 (en) 1997-07-24
PL327818A1 (en) 1999-01-04
EP0876158B1 (en) 2002-06-12
AU1323797A (en) 1997-08-11
US5977159A (en) 1999-11-02
SK282781B6 (sk) 2002-12-03
MY129782A (en) 2007-04-30
DE69621834T2 (de) 2003-03-06
SI0876158T1 (en) 2002-12-31
ES2175182T3 (es) 2002-11-16
UA49861C2 (uk) 2002-10-15
ATE218885T1 (de) 2002-06-15
HK1014870A1 (en) 1999-10-08
ID16186A (id) 1997-09-11
RU2203092C2 (ru) 2003-04-27
SK87998A3 (en) 1998-12-02
EP0876158A1 (en) 1998-11-11
CN1207685A (zh) 1999-02-10
MX9805506A (es) 1998-11-30
EE9800203A (et) 1998-12-15
DE69621834D1 (de) 2002-07-18
IL125195A0 (en) 1999-03-12
TR199801298T2 (xx) 1998-10-21
BR9612483A (pt) 1999-07-13
NO983234D0 (no) 1998-07-14
CZ222398A3 (cs) 1998-11-11
KR19990076973A (ko) 1999-10-25
NO983234L (no) 1998-07-14
AU710846B2 (en) 1999-09-30
DK0876158T3 (da) 2002-08-19
JP2001501908A (ja) 2001-02-13
IS4778A (is) 1998-06-19
ZA9783B (en) 1997-07-15
HUP9901353A2 (hu) 1999-08-30
EE03517B1 (et) 2001-10-15
PT876158E (pt) 2002-10-31
CN1090031C (zh) 2002-09-04
NZ325973A (en) 2001-05-25
HUP9901353A3 (en) 2000-05-29

Similar Documents

Publication Publication Date Title
EP1212081B1 (en) Use of ace inhibitors in the prevention of congestive heart failure
US5977159A (en) Medical use of an ace-inhibitor for treatment of dyspeptic symptoms
JP2003508426A5 (et)
RU98113650A (ru) Новое медицинское применение ингибитора ангиотензин-конвертирующего фермента (акф) для лечения диспептических симптомов
HK1014870B (en) Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms
WO2005020971A1 (en) Use of an angiotensin ii antagonist for the prevention of myocardial infarction
CA2500709A1 (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees